On Friday, a U.S. appeals court revived a lawsuit by healthcare and drug industry groups challenging the first-ever U.S. law […]
US Appeals Court Revives Lawsuit Challenging Drug Price Negotiation Program Read More »
FRANKFURT – On Friday, Sanofi (NASDAQ: SNY) said that its multiple sclerosis drug candidate was shown to delay the worsening
Sanofi (NASDAQ: SNY) Reports Key Milestone in Multiple Sclerosis Drug Development Read More »
The European Medicines Agency backed the use of Novo Nordisk’s (NYSE: NVO) popular drug Wegovy to help ease heart failure
EU Regulator Approves Novo’s Wegovy for Obesity-Related Heart Condition Read More »
Smaller rivals to UnitedHealth’s tech unit Change Healthcare say they are signing longer-term contracts with hospitals and other customers who
UnitedHealth Tech Unit’s Rivals Say New, Post-Hack Customers Are Staying Read More »
NEW YORK – On Wednesday, Hims & Hers Health (NYSE: HIMS), the U.S. telehealth company, said it will sell compounded
Hims & Hers (NYSE: HIMS) Offers Compounded Wegovy for $99/Month to Select Professions Read More »
On Wednesday, GSK (NYSE: GSK), the British drugmaker, said it had agreed to settle two lawsuits in California that claimed
GSK (NYSE: GSK) Settles Two California Lawsuits Over Heartburn Drug Zantac Read More »
Novo Nordisk (NYSE: NVO), the Danish drugmaker, expects its diabetes drug Ozempic will “very likely” be on the U.S. government’s
On Tuesday, U.S. Senator Bernie Sanders said he received confirmation from major generic pharmaceutical companies that they could sell copycat
US Senator Sanders Says Generic Drugmakers Could Offer Ozempic for Under $100/Month Read More »
Walgreens Boots Alliance (NASDAQ: WBA) agreed to pay $106.8 million to settle charges it fraudulently billed the U.S. government for
